series-a
Stage
2
Investors
About
DeepScan Diagnostics develops a comprehensive cancer test capable of detecting the most prevalent cancers in dogs months before clinical signals are shown, improving treatment outcomes. Their tests are sold at veterinary clinics as part of yearly health checks or as standalone tests.
Explore DeepScan Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.